Elevated gelatinase activity in pulmonary alveolar proteinosis: Role of macrophage-colony stimulating factor

Journal of Leukocyte Biology

Volumn 79, Issue 1, 2006, Pages 133-139

  Bonfield, Tracey L ^a   Swaisgood, Carmen M ^a   Barna, Barbara P ^a   Farver, Carol F ^a   Kavuru, Mani S ^a   Thomassen, Mary Jane ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Alveolar macrophages; GM CSF; Matrix metalloproteinases; Surfactant

Indexed keywords

ALPHA 2 MACROGLOBULIN; COLONY STIMULATING FACTOR 1; GELATIN; GELATINASE A; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LUNG SURFACTANT; MESSENGER RNA; PHOSPHOLIPID; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BRONCHUS MUCOSA; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FLUOROMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS PROTEINOSIS; LUNG LAVAGE; MACROPHAGE ACTIVATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

ANIMALS; BRONCHOALVEOLAR LAVAGE; EPITHELIAL CELLS; GELATINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LUNG; MACROPHAGE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES, ALVEOLAR; MATRIX METALLOPROTEINASES; MICE; MICE, KNOCKOUT; PULMONARY ALVEOLAR PROTEINOSIS;

ANIMALIA;

EID: 30144445531     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0805447     Document Type: Article

References (53)

1. Parks, W. C., Shapiro, S. D. (2001) Matrix metalloproteinases in lung biology. Respir. Res. 2, 10-19.
2. Visse, R., Nagase, H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839.
3. Winkler, M. K., Fowlkes, J. L. (2002) Metalloproteinase and growth factor interactions: do they play a role in pulmonary fibrosis? Am. J. Physiol. Lung Cell. Mol. Physiol. 283, L1-11.
4. Cawston, T., Carrere, S., Catterall, J., Duggleby, R., Elliott, S., Shingleton, B., Rowan, A. (2001) Matrix metalloproteinases and TIMPs: properties and implications for the treatment of chronic obstructive pulmonary disease. Novartis Found. Symp. 234, 205-218.
5. Cohn, L., Elias, J. A., Chupp, G. L. (2004) Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22, 789-815.
6. Cataldo, D. D., Gueders, M. M., Rocks, N., Sounni, N. E., Evrard, B., Bartsch, P., Louis, R., Noel, A., Foidart, J. M. (2003) Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors. Cell. Mol. Biol. (Noisy-le-grand) 49, 875-884.
7. Fukuda, Y., Ishizaki, M., Kudoh, S., Kitaichi, M., Yamanaka, N. (1998) Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab. Invest. 78, 687-698.
8. Lanone, S., Zheng, T., Zhu, Z., Liu, W., Lee, C. G., Ma, B., Chen, Q., Homer, R. J., Wang, J., Rabach, L. A., Rabach, M. E., Shipley, J. M., Shapiro, S. D., Senior, R. M., Elias, J. A. (2002) Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J. Clin. Invest. 110, 463-474.
9. Kelly, E. A., Jarjour, N. N. (2003) Role of matrix metalloproteinases in asthma. Curr. Opin. Pulm. Med. 9, 28-33.
10. Henry, M. T., McMahon, K., Mackarel, A. J., Prikk, K., Sorsa, T., Maisi, P., Sepper, R., Fitzgerald, M. X., O'Connor, C. M. (2002) Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. Eur. Respir. J. 20, 1220-1227.
11. DeMello, D. E., Lin, Z. (2001) Pulmonary alveolar proteinosis: a review. Pediatr. Pathol. Mol. Med. 20, 413-432.
12. Kitamura, T., Tanaka, N., Watanabe, J., Uchida, K., Kanegasaki, S., Yamada, Y., Nakata, K. (1999) Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 190, 875-880.
13. Dranoff, G., Crawford, A. D., Sadelain, M., Ream, B., Rashid, A., Bronson, R. T., Dickersin, G. R., Bachurski, C. J., Mark, E. L., Whitsett, J. A., Mulligan, R. C. (1994) Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264, 713-716.
14. Stanley, E., Lieschke, G. J., Grail, D., Metcalf, D., Hodgson, G., Gall, J. A. M., Maher, D. W., Cebon, J., Sinickas, V., Dunn, A. R. (1994) Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91, 5592-5596.
15. Huffman, J. A., Hull, W. M., Dranoff, G., Mulligan, R. C., Whitsett, J. A. (1996) Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J. Clin. Invest. 97, 649-655.
16. Thomassen, M. J., Yi, T., Raychaudhuri, B., Malur, A., Kavuru, M. S. (2000) Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Clin. Immunol. 95, 85-92.
17. Bonfield, T. L., Russell, D., Burgess, S., Malur, A., Kavuru, M. S., Thomassen, M. J. (2002) Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am. J. Respir. Cell Mol. Biol. 27, 481-486.
18. Shibata, Y., Berclaz, Y. P., Chroneos, Z. C., Yoshida, M., Whitsett, J. A., Trapnell, B. C. (2001) GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 15, 557-567.
19. Hart, P. H., Bonder, C. S., Balogh, J., Dickensheets, H. L., Donnelly, R. P., Finlay-Jones, J. J. (1999) Differential responses of human monocytes and macrophages to IL-4 and IL-13. J. Leukoc. Biol. 66, 575-578.
20. Andreutti, D., Gabbiani, G., Neuville, P. (1998) Early granulocyte-macrophage colony-stimulating factor expression by alveolar inflammatory cells during bleomycin-induced rat lung fibrosis. Lab. Invest. 78, 1493-1502.
21. Charbeneau, R. P., Christensen, P. J., Chrisman, C. J., Paine III, R., Toews, G. B., Peters-Golden, M., Moore, B. B. (2003) Impaired synthesis of prostaglandin E2 by lung fibroblasts and alveolar epithelial cells from GM-CSF-/- mice: implications for fibroproliferation. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L1103-L1111.
22. Kuropkat, C., Duenne, A. A., Herz, U., Renz, H., Werner, J. A. (2004) Significant correlation of matrix metalloproteinase and macrophage colony-stimulating factor serum concentrations in patients with head and neck cancer. Neoplasma 51, 375-378.
23. Re, F., Belyanskaya, S. L., Riese, R. J., Cipriani, B., Fischer, F. R., Granucci, F., Ricciardi-Castagnoli, P., Brosnan, C., Stern, L. J., Strominger, J. L., Santambrogio, L. (2002) Granulocyte-macrophage colony-stimulating factor induces an expression program in neonatal microglia that primes them for antigen presentation. J. Immunol. 169, 2264-2273.
24. Shah, P. L., Hansell, D., Lawson, P. R., Reid, K. B. M., Morgan, C. (2000) Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax 55, 67-77.
25. Kavuru, M. S., Sullivan, E. J., Piccin, R., Thomassen, M. J., Stoller, J. K. (2000) Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am. J. Respir. Crit. Care Med. 161, 1143-1148.
26. Bonfield, T. L., Kavuru, M. S., Thomassen, M. J. (2002) Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clin. Immunol. 105, 342-350.
27. Bonfield, T. L., Farver, C. F., Barna, B. P., Malur, A., Abraham, S., Raychaudhuri, B., Kavuru, M. S., Thomassen, M. J. (2003) PPARγ is deficient in alveolar macrophages from patients with alveolar proteinosis. Am. J. Respir. Cell Mol. Biol. 29, 677-682.
28. Dinakar, C., Malur, A., Raychaudhuri, B., Buhrow, L., Melton, A. L., Kavuru, M., Thomassen, M. J. (1999) Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide. Ann. Allergy Asthma Immunol. 82, 217-222.
29. Raychaudhuri, B., Bonfield, T. L., Malur, A., Hague, K., Kavuru, M. S., Arroliga, A. C., Thomassen, M. J. (2002) Circulating monocytes from patients with primary pulmonary hypertension are hyporesponsive. Clin. Immunol. 104, 191-198.
30. Venkateshiah, S. B., Thomassen, M. J., Kavuru, M. S. (2004) Pulmonary alveolar proteinosis. Clinical manifestations and optimal treatment strategies. Treat. Respir. Med. 3, 217-227.
31. Bonfield, T. L., John, N., Malur, A., Barna, B. P., Culver, D. A., Kavuru, M. S., Thomassen, M. J. (2005) Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression. Clin. Immunol. 114, 79-85.
32. Iyonaga, K., Suga, M., Yamamoto, T., Ichiyasu, H., Miyakawa, M., Ando, M. (1999) Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis. Eur. Respir. J. 14, 383-389.
33. Presneill, J. J., Nakata, K., Inoue, Y., Seymour, J. F. (2004) Pulmonary alveolar proteinosis. Clin. Chest Med. 25, 593-613.
34. Godwin, J. D., Muller, N. L., Takasugi, J. E. (1988) Pulmonary alveolar proteinosis: CT findings. Radiology 169, 609-613.
35. McQuibban, G. A., Gong, J. H., Wong, J. P., Wallace, J. L., Clark-Lewis, I., Overall, C. M. (2002) Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100, 1160-1167.
36. Furuie, H., Yamasaki, H., Suga, M., Ando, M. (1997) Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis. Eur. Respir. J. 10, 787-794.
37. Huaux, F., Arras, M., Vink, A., Renauld, J. C., Lison, D. (1999) Soluble tumor necrosis factor (TNF) receptors p55 and p75 and interleukin-10 downregulate TNF-α activity during the lung response to silica particles in NMRI mice. Am. J. Respir. Cell Mol. Biol. 21, 137-145.
38. Randow, F., Docke, W. D., Bundschuh, D. S., Hartung, T., Wendel, A., Volk, H. D. (1997) In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-γ, IL-12, and granulocyte-macrophage colony-stimulating factor. J. Immunol. 158, 2911-2918.
39. McInnes, I. B., Gracie, J. A., Leung, B. P., Wei, X-Q., Liew, F. Y. (2000) Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol. Today 21, 312-315.
40. Li, G., Kim, Y. J., Broxmeyer, H. E. (2005) Macrophage colony-stimulating factor drives cord blood monocyte differentiation into IL-10(high)IL-12absent dendritic cells with tolerogenic potential. J. Immunol. 174, 4706-4717.
41. Thomassen, M. J., Raychaudhuri, B., Bonfield, T. L., Malur, A., Abraham, S., Barna, B. P., Kavuru, M. S. (2003) Elevated IL-10 inhibits GM-CSF synthesis in pulmonary alveolar proteinosis. Autoimmunity 36, 285-290.
42. Thomassen, M. J., Antal, J. M., Barna, B. P., Divis, L. T., Meeker, D. P., Wiedemann, H. P. (1996) Surfactant downregulates synthesis of DNA and inflammatory mediators in normal human lung fibroblasts. Am. J. Physiol. 270, L159-L163.
43. Borron, P. J., Mostaghel, E. A., Doyle, C., Walsh, E. S., McHeyzer-Williams, M. G., Wright, J. R. (2002) Pulmonary surfactant proteins A and D directly suppress CD3+/CD4+ cell function: evidence for two shared mechanisms. J. Immunol. 169, 5844-5850.
44. Borron, P. J., Crouch, E. C., Lewis, J. F., Wright, J. R., Possmayer, F., Fraher, L. J. (1998) Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J. Immunol. 161, 4599-4603.
45. Brinker, K. G., Garner, H., Wright, J. R. (2003) Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells. Am. J. Physiol. Lung Cell Mol. Physiol. 284, L232-L241.
46. Baron, C. L., Scholl, S. M., Bausinger, H., Hanau, D., Pouillart, P., Goud, B., Salamero, J. (1999) Two distinct cell populations are obtained from human blood monocytes cultured with M-CSF, GM-CSF and IL-4. Eur. J. Cancer 35, S39-S40.
47. De, A. K., Laudanski, K., Miller-Graziano, C. L. (2003) Failure of monocytes of trauma patients to convert to immature dendritic cells is related to preferential macrophage-colony-stimulating factor-driven macrophage differentiation. J. Immunol. 170, 6355-6362.
48. Goyal, A., Wang, Y., Graham, M. M., Doseff, A. I., Bhatt, N. Y., Marsh, C. B. (2002) Monocyte survival factors induce Akt activation and suppress caspase-3. Am. J. Respir. Cell Mol. Biol. 26, 224-230.
49. Kimball, E. S., Kovacs, E., Clark, M. C., Schneider, C. R. (1995) Activation of cytokine production and adhesion molecule expression on THP-1 myelomonocytic cells by macrophage colony-stimulating factor in combination with interferon-γ. J. Leukoc. Biol. 58, 585-594.
50. Fixe, P., Praloran, V. (1998) M-CSF: haematopoietic growth factor or inflammatory cytokine? Cytokine 10, 32-37.
51. Shibata, Y., Zsengeller, Z. K., Otake, K., Palaniyar, N., Trapnell, B. C. (2001) Alveolar macrophage deficiency in osteopetrotic mice deficient in macrophage colony-stimulating factor is spontaneously corrected with age and associated with matrix metalloproteinase expression and emphysema. Blood 98, 2845-2852.
52. Seymour, J. F., Lieschke, G. J., Grail, D., Quilici, C., Hodgson, G., Dunn, A. R. (1997) Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood 90, 3037-3049.
53. Lieschke, G. J., Stanley, E., Grail, D., Hodgson, G., Sinickas, V., Gall, J. A., Sinclair, R. A., Dunn, A. R. (1994) Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease. Blood 84, 27-35.